What is CRP and what does it measure?

C-reactive protein (CRP) is a protein produced by the liver in response to inflammatory signaling, primarily interleukin-6 released by tissues under stress, infection, or injury. CRP rises within 6 to 12 hours of an inflammatory trigger and is a sensitive but nonspecific marker: it signals that inflammation is present but does not identify the source.

What is the difference between CRP and hs-CRP?

Standard CRP detects significant inflammation or infection and is reported in mg/L with a normal upper limit around 5 to 10 mg/L. High-sensitivity CRP (hs-CRP) operates on a finer scale to detect the low-grade chronic inflammation associated with cardiovascular risk, with meaningful thresholds at 1.0 and 3.0 mg/L. The two tests are not interchangeable.

What is a normal hs-CRP level for cardiovascular risk?

The American Heart Association and CDC define three cardiovascular risk categories: below 1.0 mg/L (low risk), 1.0 to 3.0 mg/L (intermediate risk), and above 3.0 mg/L (elevated risk). Values above 10 mg/L may indicate an acute inflammatory process and should be evaluated before being used for cardiovascular risk assessment.

What causes elevated CRP?

Bacterial infections produce the most dramatic elevations, often exceeding 100 mg/L. Viral infections cause more modest rises. Autoimmune and inflammatory conditions such as rheumatoid arthritis, cardiovascular disease, metabolic syndrome, obesity, smoking, poor sleep, and recent surgery or trauma all contribute to elevated CRP through distinct mechanisms.

What does a CRP of 50 mg/L indicate?

A standard CRP of 50 mg/L indicates moderate to significant acute inflammation. Common causes at this level include bacterial infection, an active autoimmune flare, or substantial tissue injury. This level is unlikely to represent chronic low-grade inflammation and warrants clinical evaluation to identify the underlying source.

Can CRP be high when you feel perfectly fine?

Yes. hs-CRP can be persistently elevated in the 1 to 5 mg/L range in individuals without acute symptoms. This pattern is associated with visceral adiposity, insulin resistance, poor sleep, smoking, and chronic psychological stress. Low-grade chronic inflammation at this level carries long-term cardiovascular and metabolic relevance even without symptoms.

How often should hs-CRP be tested?

For cardiovascular risk monitoring, annual hs-CRP assessment is reasonable as part of a broader risk profile. A single elevated reading is typically repeated after 2 weeks before drawing clinical conclusions, as transient elevations from minor illness or exertion are common. Retesting every 3 months is appropriate when actively working to reduce chronic inflammation through lifestyle changes.

Does losing weight lower CRP levels?

Weight loss, particularly reduction in visceral adipose tissue, is associated with meaningful reductions in hs-CRP. Visceral fat releases pro-inflammatory cytokines that drive hepatic CRP production, so adiposity reduction directly addresses one of the primary drivers of chronic low-grade inflammation. The effect is most pronounced with sustained weight loss of 5 percent or more of body weight.

What CRP Level Is Dangerous? Chart and Thresholds

Creator: Superpower
Published: 2026-04-03

Understand what your immune health results really mean

See your biomarkers in context with a comprehensive panel.

CLIA-certified labs
HIPAA compliant
Personalized health protocol

Book your test

Standard CRP above 100 mg/L warrants clinical evaluation within 24 to 48 hours. hs-CRP above 3 mg/L signals elevated cardiovascular risk, and above 10 mg/L usually points to an acute process.

What CRP measures, and what hs-CRP measures differently

C-reactive protein is a protein produced by the liver in response to inflammatory signaling, particularly interleukin-6 (IL-6) released from tissues under stress, infection, or injury. CRP levels rise rapidly — within 6 to 12 hours — and can increase one-thousand-fold in severe acute inflammation, making it a sensitive but non-specific marker of inflammatory activity. CRP tells you inflammation is present, not what is causing it; a high result is a prompt to investigate further, not a conclusion in itself.

There are two distinct versions of this test in clinical use: standard CRP, ordered when acute or significant inflammation is suspected, and high-sensitivity CRP (hs-CRP), designed to detect the lower-grade chronic inflammation associated with cardiovascular risk. This article uses two scales accordingly — standard CRP for acute inflammation, and hs-CRP for chronic cardiovascular risk. The thresholds are not interchangeable.

Routine elevation vs urgent-evaluation CRP values

The chart below combines the AHA/CDC hs-CRP risk bands with the patterns that warrant prompt clinical evaluation. Divide a mg/L value by 10 to get mg/dL.

Test	Range, mg/L (mg/dL)	What it means	Next step
hs-CRP	Below 1.0 (below 0.1)	Low cardiovascular risk	Standard follow-up
hs-CRP	1.0 to 3.0 (0.1 to 0.3)	Intermediate cardiovascular risk	Lifestyle review; repeat at 12 weeks if still elevated
hs-CRP	Above 3.0 (above 0.3)	Elevated cardiovascular risk	Clinical review and broader cardiovascular panel
hs-CRP	Above 3.0 (above 0.3), with multiple cardiovascular risk factors and no prior risk assessment	Elevated risk not yet assessed	Primary care or cardiology consultation
hs-CRP	Above 10 (above 1.0)	Acute process likely	Acute workup before cardiovascular interpretation
hs-CRP	Persistently above 10 (above 1.0), no identified acute trigger	Possible occult infection, malignancy, or active inflammatory disease	Provider-directed evaluation
Standard CRP	Above 100 (above 10), especially with fever, systemic symptoms, or rapid deterioration	Consistent with serious bacterial infection or inflammatory crisis	Clinical evaluation within 24 to 48 hours
Any CRP	Rising rather than falling during recovery from illness or surgery	Recovery not on track	Prompt clinical evaluation

Routine follow-up tier

An hs-CRP of 1–10 mg/L in an asymptomatic person, or a standard CRP mildly above normal without accompanying symptoms, most often reflects low-grade chronic inflammation rather than an acute process. Common underlying contributors include subclinical insulin resistance, visceral adiposity, poor sleep, chronic psychological stress, and early autoimmune activity. The appropriate response is to discuss the result with a provider alongside cardiovascular risk markers, complete a lifestyle assessment, and confirm the reading with a repeat test if the acuity of the elevation is unclear. A broader panel including HbA1c, fasting glucose, lipid markers, and TSH helps characterize the broader context of the elevation.

Urgent and emergent evaluation tier

There is no single CRP threshold that uniformly signals danger, because severity depends entirely on clinical context. The standard CRP, persistent hs-CRP, and rising-CRP rows in the table above are the patterns that warrant prompt clinical evaluation.

A very high CRP does not itself constitute an emergency. It is a biomarker indicating that the clinical picture requires investigation; the urgency of that investigation is determined by accompanying symptoms, clinical history, and the trajectory of the value over time. A doctor who sees a high CRP will go over the result with you and usually order additional tests to find the cause.

What actually shifts CRP between draws

Acute bacterial and viral infection

Bacterial infections produce the most dramatic CRP elevations, often driving standard CRP values above 100 mg/L within 24 to 48 hours of onset. Viral infections typically cause more modest elevations, rarely exceeding 40–50 mg/L. CRP is used clinically to help distinguish bacterial from viral illness, though it is not definitive on its own. In most cases of uncomplicated infection, CRP normalizes within days to weeks of resolution; a persistently elevated CRP following recovery warrants further evaluation. The one-thousand-fold rise possible in severe acute inflammation is well established across decades of clinical evidence.

Autoimmune and chronic inflammatory conditions

Conditions including rheumatoid arthritis, lupus, inflammatory bowel disease, and vasculitis are associated with sustained CRP elevations that fluctuate with disease activity. Monitoring CRP over time can help characterize disease severity and treatment response in these settings, though it is always interpreted alongside disease-specific markers. Notably, some autoimmune conditions — lupus in particular — may not produce the expected CRP elevation during flares, which can complicate interpretation.

Cardiovascular disease and metabolic syndrome

Chronic low-grade inflammation, reflected in persistently elevated hs-CRP, is well established as a component of cardiovascular risk alongside traditional lipid markers. A landmark 2024 study in the New England Journal of Medicine found that a combined measure of hs-CRP, LDL cholesterol, and lipoprotein(a) predicted 30-year cardiovascular outcomes in initially healthy women, reinforcing hs-CRP's role as part of a broader cardiovascular risk picture rather than an isolated marker. A large cohort study also demonstrated that low-grade inflammation measured by hs-CRP was independently associated with cardiovascular events in patients with type 2 diabetes, supporting its clinical utility in metabolic contexts.

Obesity and visceral adiposity

Body mass index and visceral fat are among the strongest non-pathological determinants of hs-CRP. Adipose tissue releases pro-inflammatory cytokines that stimulate hepatic CRP production, and elevated hs-CRP is also associated with insulin resistance and metabolic syndrome. These factors may produce hs-CRP values in the 1–3 mg/L intermediate range in otherwise healthy individuals — clinically relevant because even modestly elevated chronic inflammation is associated with long-term cardiovascular and metabolic risk. The BMI–CRP association is supported by large observational data; the cytokine mechanism is established, though intervention evidence at this level of specificity remains limited.

Poor sleep, smoking, and psychological stress

Smoking, sedentary behavior, and poor sleep quality independently elevate CRP through inflammatory mechanisms. Chronic psychological stress has also been associated with modestly elevated hs-CRP in observational studies. These associations are real but should be interpreted cautiously: the evidence is observational, and no controlled intervention trials have isolated these factors at the specificity needed to quantify their individual contribution to CRP elevation.

Evidence-graded levers for lowering chronic hs-CRP

Step 1: Repeat hs-CRP after 2 weeks before drawing clinical conclusions

Transient elevations from minor illness, strenuous exercise, or recent injury are common, and a single elevated hs-CRP reading is not sufficient to draw cardiovascular risk conclusions. The American Heart Association recommends repeat testing after 2 weeks under standardized conditions — fasted, rested, and at least 2 weeks from any acute illness or strenuous exercise — before acting on the result. This step applies whenever a single elevated hs-CRP reading has not yet been confirmed.

Step 2: Address the lifestyle drivers you can change

Weight loss, smoking cessation, and improved sleep are each associated with reductions in hs-CRP in observational and intervention data. If a persistent hs-CRP above 1 mg/L is accompanied by an identifiable lifestyle contributor — visceral adiposity, active smoking, or chronic sleep disruption — addressing that contributor is the appropriate first-line response. Retest hs-CRP at 12 weeks to assess response.

Step 3: Seek clinical evaluation for standard CRP above 100 mg/L or hs-CRP persistently above 10 mg/L

These thresholds reflect clinical consensus for when self-directed monitoring is insufficient. The table in the urgent-evaluation section lists each one and its timeframe. Further testing and cadence are provider-directed from this point.

Common misreads of a single elevated CRP

Concluding from a single hs-CRP reading. Transient elevations from minor illness, strenuous exercise, or recent injury are common, so confirm an elevated result with the repeat test in Step 1 first.
Using standard CRP and hs-CRP interchangeably. Standard CRP detects significant acute inflammation (normal <5–10 mg/L); hs-CRP operates on a finer scale for cardiovascular risk stratification. Reporting units and clinical meaning differ — a result from one test cannot be interpreted against the reference range of the other.
Stopping antibiotic or anti-inflammatory therapy because CRP dropped. A falling CRP during treatment is reassuring, but premature cessation based on one lower reading risks recurrence or incomplete resolution. The decision to stop treatment is provider-driven, not biomarker-driven.
Assuming a high CRP means cancer. CRP is not a cancer marker; it reflects inflammation from any cause. Most elevated CRP values reflect infection, autoimmune disease, or metabolic and lifestyle factors. Persistent unexplained elevation warrants clinical workup — not assumption about the underlying cause.

Test 100+ biomarkers

One blood draw. A full picture of your health, explained in plain language.

Book your test

Test 100+ biomarkers

One blood draw. A full picture of your health, explained in plain language.

Book your test

How quickly can CRP levels change?

CRP retest timing depends on whether the elevation is acute or chronic.

Acute CRP (standard CRP, suspected infection or injury): If the triggering cause resolves, standard CRP typically normalizes within 1–3 days for viral illness and within days to weeks for bacterial infection or tissue injury. Post-surgical CRP typically peaks at 48–72 hours and normalizes over 7–14 days in uncomplicated recovery. A CRP that fails to normalize or re-elevates after initial decline may indicate surgical site infection or other complication requiring clinical assessment.

Chronic hs-CRP (cardiovascular risk monitoring): For lifestyle or statin-based interventions targeting chronic elevation, allow 4–12 weeks before retesting. A 3-month cadence is appropriate for ongoing optimization monitoring.

Standardized conditions for all hs-CRP draws: fasted, rested, and at least 2 weeks from any acute illness or strenuous exercise.

Companion panel for retest context: hs-CRP, HbA1c, ApoB.

When an elevated CRP belongs with a clinician

Bring a CRP result to a clinician when it matches any urgent row in the table above; for hs-CRP above 3 mg/L with multiple cardiovascular risk factors, the pathway is a primary care or cardiology consultation.

hs-CRP is most informative when assessed alongside HbA1c, ApoB, Lp(a), and other cardiovascular markers rather than in isolation. Understanding your full inflammatory and metabolic picture is part of the Superpower approach to proactive health.